Reduced Testosterone Levels (ADT) in Men with Bony Metastatic Prostate Cancer Increases Survival Time
A study from Milan Italy look at the controversy, does the testosterone level achieved with androgen-deprivation therapy (ADT) increase the survival in men with metastatic prostate cancer? ADT comes with significant morbidity issues, so is there an adequate benefit from ADT (does it provide survival benefits) to balance out the negative side effects? This [...]